远程青光眼与住院检查用于青光眼筛查的有效性:一项系统综述和荟萃分析

基于45项研究的系统综述与荟萃分析,评估远程青光眼筛查的诊断准确性和成本效益,数据为文本形式。

Figshare
2016-01-15 更新
浏览 14
文本screeningscreen test resultsTeleglaucomahealthcare system benefitshealthcare service qualityassessed.ResultsOf 11237 studiesglaucoma caseshealthcare systems benefitspecialist referral ratesciscreen testodd
The Effectiveness of Teleglaucoma versus In-Patient Examination for Glaucoma Screening: A Systematic Review and Meta-Analysis

基本信息

模态
文本
大小
0.000059596 GB
许可
CC BY 4.0
创建/更新时间
2016-01-15
版本
v1

资源简介

远程青光眼与住院检查用于青光眼筛查的有效性:一项系统综述和荟萃分析

【数据集背景】

本数据集源站标题为《The Effectiveness of Teleglaucoma versus In-Patient Examination for Glaucoma Screening: A Systematic Review and Meta-Analysis》。配套论文《The Effectiveness of Teleglaucoma versus In-Patient Examination for Glaucoma Screening: A Systematic Review and Meta-Analysis》发表于 PLoS ONE(2014),DOI:10.1371/journal.pone.0113779。源站首次发布:2014-12-05。

【数据内容】

源站原始描述:Background Glaucoma is the leading cause of irreversible visual impairment in the world affecting 60.5 million people worldwide in 2010, which is expected to increase to approximately 79.6 million by 2020. Therefore, glaucoma screening is important to detect, diagnose, and treat patients at the earlier stages to prevent disease progression and vision loss. Teleglaucoma uses stereoscopic digital imaging to take ocular images, which are transmitted electronically to an ocular specialist. The purpo…

【数据结构与技术规格】

文件数 3 个,合计 59.60 KB。Table_S1.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,15.97 KB。Table_S2.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,24.38 KB。Table_S3.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,19.25 KB。数据集 DOI:10.1371/journal.pone.0113779。

【主题与分类】

源站学科分类:Biological Sciences、Science Policy。主题标签:screening、screen test results、Teleglaucoma、healthcare system benefits、healthcare service quality、assessed.ResultsOf 11237 studies、glaucoma cases、healthcare systems benefit、specialist referral rates、ci。

【适用方向】

文本类数据可用于医学自然语言处理,如命名实体识别、信息抽取与文本分类。

【获取与许可】

源站页面:https://plos.figshare.com/articles/dataset/_The_Effectiveness_of_Teleglaucoma_versus_In_Patient_Examination_for_Glaucoma_Screening_A_Systematic_Review_and_Meta_Analysis_/1262825

使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。

规范引用:Thomas, Sera-Melisa; Jeyaraman, Maya; G. Hodge, William; Hutnik, Cindy; Costella, John; S. Malvankar-Mehta, Monali (2016). The Effectiveness of Teleglaucoma versus In-Patient Examination for Glaucoma Screening: A Systematic Review and Meta-Analysis. PLOS ONE. Dataset

【使用注意】

· 源站最后修改于 2023-06-02,引用时请注意版本时效。

官方服务

专家保障全链路合规授权与标注交付

陕川双基地 × 超十家三甲医院直连

从合规授权、采集治理、专业标注到数据集交付,我们提供全链路闭环服务,让高质量临床数据即拿即用。

⚡️ 需要原始数据或标注支持?联系我们获取定制方案。

帮我联系

下载信息

注册下载

需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。

暂未开放

公开下载

无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。

免登录

有偿下载

公开数据集受托下载与技术交付服务。

提供高速下载与技术交付服务(收技术服务费,非数据销售)

暂未开放

当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。

使用方式

数据集获取(Figshare)

命令行下载

curl -L -o "Table_S1.docx" "https://ndownloader.figshare.com/files/1826339"
curl -L -o "Table_S2.docx" "https://ndownloader.figshare.com/files/1826340"
curl -L -o "Table_S3.docx" "https://ndownloader.figshare.com/files/1826341"

文件清单

  • Table_S1.docx(15.97 KB)
  • Table_S2.docx(24.38 KB)
  • Table_S3.docx(19.25 KB)

文件总体积 59.60 KB(源站 API 实测)。

数据加载示例(图像类)

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

Background
Glaucoma is the leading cause of irreversible visual impairment in the world affecting 60.5 million people worldwide in 2010, which is expected to increase to approximately 79.6 million by 2020. Therefore, glaucoma screening is important to detect, diagnose, and treat patients at the earlier stages to prevent disease progression and vision loss. Teleglaucoma uses stereoscopic digital imaging to take ocular images, which are transmitted electronically to an ocular specialist. The purpose is to synthesize literature to evaluate teleglaucoma, its diagnostic accuracy, healthcare system benefits, and cost-effectiveness.
Methods
A systematic search was conducted to help locate published and unpublished studies. Studies which evaluate teleglaucoma as a screening device for glaucoma were included. A meta-analysis was conducted to provide estimates of diagnostic accuracy, diagnostic odds ratio, and the relative percentage of glaucoma cases detected. The improvements to healthcare service quality and cost data were assessed.
Results
Of 11237 studies reviewed, 45 were included. Our results indicated that, teleglaucoma is more specific and less sensitive than in-person examination. The pooled estimates of sensitivity was 0.832 [95% CI 0.770, 0.881] and specificity was 0.790 [95% CI 0.668, 0.876]. The relative odds of a positive screen test in glaucoma cases are 18.7 times more likely than a negative screen test in a non-glaucoma cases. Additionally, the mean cost for every case of glaucoma detected was $1098.67 US and of teleglaucoma per patient screened was $922.77 US.
Conclusion
Teleglaucoma can accurately discriminate between screen test results with greater odds for positive cases. It detects more cases of glaucoma than in-person examination. Both patients and the healthcare systems benefit from early detection, reduction in wait and travel times, increased specialist referral rates, and cost savings. Teleglaucoma is an effective screening tool for glaucoma specifically for remote and under-services communities.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.1371/journal.pone.0113779(source: https://plos.figshare.com/articles/dataset/_The_Effectiveness_of_Teleglaucoma_versus_In_Patient_Examination_for_Glaucoma_Screening_A_Systematic_Review_and_Meta_Analysis_/1262825)。

数据缺失?

依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。

⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。

获取专属数据定制方案